Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/7603Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sulaiman Ajaj Abdullah, Ahmed Majeed Al-Shammari | - |
| dc.contributor.author | Safaa Abed Lateef | - |
| dc.date.accessioned | 2022-10-29T11:54:21Z | - |
| dc.date.available | 2022-10-29T11:54:21Z | - |
| dc.date.issued | 2020-06-27 | - |
| dc.identifier.citation | 16 | en_US |
| dc.identifier.issn | 2213-7106 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/7603 | - |
| dc.description.abstract | Oncolytic viruses are promising anticancer therapy that can overcome resistance to current conventional therapies. Measles virus replicates in and destroys malignant cells without affecting healthy cells. The study aimed to evaluate the lives attenuated Measles virus vaccine against Iraqi patient derived breast cancer cells that have functional BRCA1/BRCA2 genes and compare its activity against international breast cancer MCF-7 and CAL-51 cell lines. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Riyadh : Saudi Biological Society : King Saud University, [2009] | en_US |
| dc.subject | AMJ13 | en_US |
| dc.subject | Breast cancer | en_US |
| dc.subject | Measles virus vaccine | en_US |
| dc.subject | Oncolytic activity | en_US |
| dc.title | Attenuated measles vaccine strain have potent oncolytic activity against Iraqi patient derived breast cancer cell line | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | كلية الصيدلة | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| سليمان 1.pdf | 4.4 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.